EE327 Cost-Effectiveness Analysis of Cemiplimab for Patients With Advanced Non-Small Cell Lung Carcinoma in Spain

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.573
https://www.valueinhealthjournal.com/article/S1098-3015(22)02777-2/fulltext
Title : EE327 Cost-Effectiveness Analysis of Cemiplimab for Patients With Advanced Non-Small Cell Lung Carcinoma in Spain
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02777-2&doi=10.1016/j.jval.2022.09.573
First page :
Section Title :
Open access? : No
Section Order : 10102
Categories :
Tags :
Regions :
ViH Article Tags :